Loading organizations...
Key people at Xenia Venture Capital.
Xenia Venture Capital operates as an investment firm, concentrating on early-stage life science and high-tech companies within Israel. It co-manages VLX, a technological incubator recognized by the Israel Innovation Authority. Xenia provides hands-on mentoring, strategic guidance, and fundraising support, actively partnering with its portfolio to facilitate growth and market entry. The firm's core approach involves identifying promising concepts and developing them into successful ventures.
Established in 2004, Xenia was founded by Anat Tsour Segal, an experienced investor and entrepreneur. Her insight aimed to cultivate Israel's high-tech ecosystem by targeting local innovations across medical, cyber, and environmental technologies addressing global challenges. Segal's background in identifying and nurturing solutions defined the firm's strategic investment approach, focusing on impactful technological advancements.
Xenia primarily supports entrepreneurs and emerging companies within Israel's life science and technology sectors. The firm transforms compelling ideas into substantial, market-ready enterprises. Its vision centers on identifying and fostering disruptive technologies, playing a key role in Israeli innovation and providing solutions for critical global needs, continuously seeking to shape future markets.
Key people at Xenia Venture Capital.
Xenia Venture Capital has 4 tracked investments across 3 companies. The latest tracked deal is $25.0M Series C in Omnix Medical in October 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 15, 2025 | Omnix Medical | $25.0M Series C | European Innovation Council, Tomer Goldberg | Entr E Capital, Oriella, OurCrowd, Prevail Partners, TAL Ventures |
| Sep 29, 2020 | keepMED | $15.2M Series C | — | 4See Ventures, C4 Ventures, Celeste Management, Financière Arbevel, Lavorel Medicare, Valerie Calenda, Pitango Venture Capital |
| Apr 29, 2015 | keepMED | $10.0M Series B | Valerie Calenda, David Israeli | — |
| Nov 12, 2010 | Superfish | $4.0M Series C | — | DFJ, Individuals' Venture Fund |